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SUMMARY
Eluted dried blood spot specimens from newborn screening, collected in 2004 in North Thames
and anonymously linked to birth registration data, were tested for maternally acquired rubella
IgG antibody as a proxy for maternal antibody concentration using an enzyme-linked
immunosorbent assay. Finite mixture regression models were ﬁtted to the antibody
concentrations from 1964 specimens. The Bayesian Information Criterion (BIC) was used as
a model selection criterion to avoid over-ﬁtting the number of mixture model components.
This allowed investigation of the independent eﬀect of maternal age and maternal country of
birth on rubella antibody concentration without dichotomizing the outcome variable using cut-oﬀ
values set a priori. Mixture models are a highly useful method of analysis in seroprevalence
studies of vaccine-preventable infections in which preset cut-oﬀ values may overestimate the size
of the seronegative population.
INTRODUCTION
Results of antibody assays may be diﬃcult to
interpret when used in population-based seroepidemi-
ological studies where quantiﬁcation of previous ex-
posure to infectious disease, either through natural
infection or vaccination, is of interest. This is partly a
consequence of the diﬃculty in applying a meaningful
cut-oﬀ value to continuous distributions of antibody
concentrations in order to deﬁne seronegativity [1].
If a sample falls below a cut-oﬀ value set by the assay
manufacturer, this does not necessarily indicate
non-immunity, as IgG antibody assays for vaccine-
preventable diseases are most often employed in
screening to indicate a need for immunization. In this
context, cut-oﬀ values are likely to be set high to
avoid false negatives [2]. It follows that using ﬁxed
cut-oﬀ values for seroepidemiological studies implies
an at best artiﬁcial, but in some cases completely
arbitrary, measure of the population at risk of infec-
tion. In addition, since the majority of antibody
assays are optimized for measuring antibody con-
centrations in serum, cut-oﬀ values provided by the
assay manufacturer may not apply if the assays have
been modiﬁed for use on other test media [3–5].
An alternative approach is to ﬁt latent-class ﬁnite
mixture models [6] to continuous distributions of
antibody concentrations in order to characterize
diﬀerent exposure categories in the population, e.g.
previously infected or vaccinated, and unexposed.
The basic assumption in a mixture model is that the
study population consists of individuals in diﬀerent
exposure subpopulations. The number of subpopu-
lations is either assumed to be known a priori or,
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more often, is a quantity of interest to be determined
from the data. In either case, mixture models provide
a convenient framework to test hypotheses relating
to the number of exposure groups in the population
and their characteristics. Mixture models have been
reported in the literature for analyses of antibody
concentrations for various infections [1, 3, 7, 8].
In this study, we ﬁt latent-class ﬁnite mixture
regression models to maternally acquired rubella IgG
antibody concentrations obtained from testing re-
sidual dried blood spots from newborn screening in
North London and surrounding counties in 2004.
Since newborn antibody concentration is used as a
proxy for maternal antibody concentration [9, 10], we
hypothesize that there would be three subpopulations,
one seronegative group, a second group with inter-
mediate antibody concentrations that has been vacci-
nated or infected but mounted a weaker antibody
response, and a third group with higher antibody
concentrations following infection or vaccination,
which is possibly more recent. This model can be
expressed as:
f(y)=plfl(y)+pmfm(y)+phfh(y), (1)
where y is antibody concentration, the parameters
(pl, pm, ph) are the component weights, and (fl, fm, fh)
are the density functions of the three components.
Maternal age and country of birth have been found
to be important predictors of maternal rubella anti-
body concentration [11]. In order to examine the
independent eﬀects of these two variables on maternal
antibody concentration, we ﬁt latent-class ﬁnite mix-
ture regression models of the form
f(y)=
XK
k=1
pk(X1, b1k) fk(y; X2b2k; X3b3k), (2)
where y is the antibody concentration, K is the
number of components, X1, X2 and X3 are design
matrices for the component weights (p), the location
and scale parameters of the kth component respect-
ively. {b1k} is the vector of parameters for the linear
predictor in each component weight, and {b2k} and
{b3k} are the location and scale parameters. We used
the identity, logarithmic and multinomial link func-
tions to ﬁt the regression parameters for location,
scale and component weights respectively. We are not
aware of any papers reporting the use of this class of
mixture regression models to analyse antibody con-
centrations. We demonstrate their usefulness in
quantifying the independent eﬀect of two or more
predictors on antibody concentration without di-
chotomizing this variable.
METHODS
Samples
We measured rubella IgG antibody concentration in
dried blood spots, left over from the North Thames
newborn screening programme. The newborn screen-
ing programme in North Thames covers inner and
outer North London, Bedfordshire, Hertfordshire
and Essex, an area with an ethnically diverse popu-
lation. All newborns are oﬀered screening at around
5–8 days of age and coverage is estimated to be close
to 100% [12]. Four spots of blood are collected on
a Schleicher & Schuell 9031 ﬁlter paper card
(Schleicher & Schuell GmbH, Dassel, Germany) from
the baby’s heel by a midwife or health visitor who
then sends the specimens to the screening laboratory.
Blood spot samples are punched from the cards, and
tested for biomarkers for inherited or congenital
conditions including phenylketonuria and congenital
hypothyroidism.
When metabolic screening has been completed, an
extra sample is punched from the screening cards and
tested for anti-HIV antibody as part of the newborn
unlinked anonymous HIV surveillance programme.
Anonymized data linkage between screening card
data and birth registration records held by the Oﬃce
for National Statistics was established for this pro-
gramme. The data linkage and HIV testing algorithm
have been described in detail elsewhere [13, 14].
Laboratory methods
Two extra samples were punched from all blood spot
cards sent to the screening laboratory between 1999
and 2006 as part of a study to serotype samples found
to be HIV positive [15]. As part of the HIV testing
protocol, dried blood spot punches are placed in
96-well plates, and eluted in PBS-Tween 20 solution.
HIV-positive samples had to be excluded from the
analyses, since the remaining eluate is used for HIV
conﬁrmatory testing. Following HIV tests, eluates
were kept at x20 xC for up to 20 months before
rubella antibody testing. Plates containing samples
received in the screening laboratory in the third
quarter of 2004 in North Thames were randomly
sampled for rubella IgG testing. A commercial
enzyme-linked immunosorbent assay (ELISA; Diesse,
Siena, Italy) was used to test for rubella IgG antibody.
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This ELISA has been found to be valid for use on
eluted dried blood spots [16]. Dried blood spot eluate
samples (50 ml each) were tested for rubella IgG anti-
body according to the manufacturer’s instructions.
The ELISA results are quantitative, given as a ratio
between the optical density reading of the sample
and a plate-speciﬁc reference sample provided by the
manufacturer. The optical densities can be converted
into antibody concentrations in international units
per millilitre (IU/ml) using a calibration curve, which
is constructed from four plate-speciﬁc reference
sample values with pre-determined antibody concen-
trations provided by the manufacturer.
Demographic data
Data on maternal age were available from screening
records, and on maternal country of birth through
data linkage to birth registration data. Maternal
country of birth was coded into a binary variable
(‘UK-born’ and ‘born abroad’).
Statistical methods
In order to amplify the values of the optical density
ratios between 0 and 1, which are of largest epidemi-
ological and clinical signiﬁcance, we modelled the
distribution of the natural logarithm of the optical
density ratio [ln(ODR)]. Low optical density values
correspond to seronegative status.
We used the FLEXMIX [17] and GAMLSS.MX [18]
packages in the R statistical software version 2.5.1
[19] to ﬁt continuous ﬁnite mixture models based
on a latent-class regression approach. Both packages
employ an expectation-maximization (EM) algorithm
that uses maximum likelihood to estimate the model
parameters and calculates the probability of belong-
ing to each component for every observation. Hence
the size of each component can be estimated as
follows: the probability that observation i belongs
to class j is given by
Pr j Xi1,Xi2,Xi3; yi; b1, b2, b3j½ =
pj(Xi1, b1j) f(yi)PK
k=1 pk(Xi1, b1k) f yið Þ
,
(3)
where j=1, 2, …, K, and i=1, 2, …, n. We used this
expression (known as Bayes’ rule) to assign each ob-
servation to the class with the maximum probability.
We used the diagnostic tools provided by these
packages to check the models’ goodness-of-ﬁt pro-
perties. We based our model selection strategy on the
Bayesian Information Criterion (BIC) [17, 20] de-
ﬁned as
BIC=x2 lnL(b^1, b^2, b^3)+p ln(n), (4)
where L is the value of the likelihood evaluated at
the estimates (b^1, b^2, b^3), p is the number of model
parameters and n is the number of independent
observations. The BIC is more conservative against
overparameterization than other model selection
criteria, which is particularly important when ﬁtting
mixture models as the optimal number of components
may otherwise be overestimated [17].
We ﬁtted mixture models to the full distribution
of the natural logarithms of the ODRs available,
assuming normal and gamma distributions for the
components allowing for up to ﬁve components and
compared the goodness of ﬁt of these models using
BIC. In order to ﬁt gamma-distributed components
we added a constant to the ln(ODR) values to ensure
they were positive. Up to ﬁve sets of maximum-like-
lihood estimates were obtained for each regression
model, the optimal model for each set of covariates
being that which minimized BIC. Increasing the
number of components beyond ﬁve resulted in empty
components. The ﬁnite mixture regression models
were then compared using a stepwise procedure to
account for one covariate for the mean at a time, then
including both variables, and ﬁnally including an in-
teraction term. Maternal age was modelled both as a
linear and as a quadratic term in the linear predictors
deﬁning the components’ means. Again, the optimal
model was that for which BIC was minimized. The
optimal regression model was also reﬁtted with cov-
ariates for the component weights and variances,
using a stepwise approach, adding more covariates, to
assess whether the models’ ﬁt improved.
Ethics approval
Ethics approval was obtained from the London
Multicentre Research Ethics Committee (MREC).
RESULTS
We analysed ln(ODR)s from 1964 dried blood spot
samples out of 1979 samples tested. Eleven samples
were excluded from analyses as they were HIV posi-
tive, and a further four because parents had opted
out of HIV testing or newborn screening. Linkage to
birth registration data was achieved for 1943 of 1964
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samples (98.9%). Data on maternal age was avail-
able for 1265 of these linked samples (65.1%). Mean
maternal age was 29.5 years (S.D.=5.9 years).
Maternal country of birth was available for 1811
samples (93.2%): 792 (43.7%) mothers were born
abroad. The distribution of ln(ODR) by maternal age
group (<25, 25–34 and o35 years) and country of
birth are shown in Figure 1(a, b).
Table 1 shows the model selection process for
the ﬁnite mixture models using the full population of
1964 samples, varying the number of mixture model
components, assuming normal or gamma distribu-
tions of the components. The former appeared to
provide a better ﬁt, and therefore all subsequent
models were based on this assumption. The model
with three normally distributed components had
the lowest BIC; the three normal density functions
correspond to the three hypothesized groups of
exposure to rubella infection (Table 2). Note that the
component weights are not equal to the proportions
of samples allocated to each component since the
former are the estimates of the parameters pl, pm and
ph and the latter were calculated using equation (3).
Figure 2 shows the densities of each component of
this model, as well as the density of the total sample
of ln(ODR).
To account for the variation in antibody concen-
tration by maternal age and country of birth, we ﬁtted
mixture regression models adjusting for these covari-
ates. In order to compare models with diﬀerent covari-
ates using the BIC, all samples for which either
maternal country of birth or maternal age was missing
had to be excluded, leaving 1236 samples for analysis.
A summary of these regression models can be found
in Table 3.
The BIC was minimized for the model where only
maternal country of birth is included as a covariate
(model 3). This model was therefore reﬁtted with
covariates for the component weights (p) and vari-
ance parameters using the same combinations of
covariates as described in Table 3.
A model in which maternal age was included as a
covariate for the component weights (with no covari-
ates for the variances) improved very marginally on
the optimal model described in Table 3 and resulting
in a BIC of 2503.6. The parameter estimates for the
linear predictors of this model are shown in Table 4a ;
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Fig. 1. Distribution of the natural logarithm of the optical
density ratio [ln(ODR)] : (a) by maternal age group (n=
1265) ; (b) by maternal country of birth (n=1811).
Table 1. Model selection procedure for univariable
ﬁnite mixture models (n=1964)
No. of components
in model D.F. BIC
Normal components
1 2 4355.2
2 5 4130.2
3 8 4055.1
4 11 4067.8
5 14 4090.3
Gamma components
1 2 4875.7
2 5 4248.0
3 8 4086.4
4 11 4075.8
5 14 4083.3
D.F., Degrees of freedom; BIC, Bayesian Information
Criterion.
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note that the functions for the component weights
are given on the multinomial scale, considering the
low component as baseline. Table 4b gives the mean
and conﬁdence interval (CI) for the components by
maternal country of birth.
The mean ODR for the low and medium mixture
model components is signiﬁcantly lower for women
born abroad than for UK-born women. However, for
UK-born women, the mean of the medium compo-
nent is not signiﬁcantly diﬀerent to that of the low
component. Figure 3 shows how the component
weights change as a function of maternal age. These
curves were obtained by applying the inverse multi-
nomial function to the linear predictors in Table 4a.
Adding a quadratic eﬀect for maternal age to these
probability functions did not improve the goodness
of ﬁt.
As maternal age increases, women are less likely to
be assigned to the low component. The probability of
being assigned to the medium component increases
with maternal age, however, the proportion in the
higher component changes little across maternal
ages. For a mother of the mean age in our sample
(29.5 years), the component weights for the low,
medium and high components are therefore 5.7%,
54.1% and 40.2% respectively.
DISCUSSION
Left-over dried blood spots from newborn screening
provide a large, relatively inexpensive, and near-
universal sampling frame within which rubella anti-
body concentrations among newly delivered women
can be investigated. However, because this implies
using newborn antibody concentration as a proxy for
maternal antibody concentration, using cut-oﬀ values
to deﬁne the seronegative population would not be
appropriate for our data. We therefore used ﬁnite
mixture models to analyse the natural logarithms
of the ODRs, as this avoids dichotomizing the out-
come variable of interest.
Several authors [1, 3] have commented on the
usefulness of ﬁnite mixture models for analysing
results of seroprevalence studies in which the speci-
ﬁcity of the antibody assay used is low. This is sup-
ported by our ﬁndings; using this approach and
assuming that the samples allocated to the component
with the lowest mean antibody concentration are
seronegative (Table 2), 3.6% of samples would be
considered antibody negative (95% CI 2.8–4.4). This
is similar to the proportion of women who were
described as susceptible through antenatal screening
in London in 2004 [21]. By applying the cut-oﬀ
recommended by the assay manufacturers (of samples
with an antibody level <7 IU/ml classed as sero-
negative), the proportion of samples that would be
Table 2. Summary of the three components in the univariable model with lowest Bayesian Information
Criterion (means and conﬁdence intervals have been anti-logged)
Component
No. of
observations
in component
Samples
(%)
Component
weights (p)
Mean
ODR S.D.
95% CI
for mean
Low 71 3.6% 6.7% 0.33 0.94 (0.18–0.62)
Medium 897 45.7% 47.4% 1.03 0.51 (0.98–1.08)
High 996 50.7% 45.9% 2.31 0.34 (2.24–2.40)
ODR, Optical density ratio, S.D., standard deviation; CI, conﬁdence interval.
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Fig. 2. The density functions of the three components of the
ﬁnite mixture model with lowest Bayesian Information
Criterion and the density function of the total distribution
of the natural logarithm of the optical density ratio
[ln(ODR)] (n=1964).
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considered seronegative is 15.3% (95% CI 13.8–
17.0), which is a gross overestimate. This emphasizes
the need for caution in applying cut-oﬀ values deter-
mined a priori, which are intended for use in a clinical
setting, without consideration for the particular
context in which they are applied, or of the specimens
used in the serosurvey.
As Figure 2 shows, there is some overlap among
the components of the mixture model. This implies
that some samples (e.g. with log optical densities
between x1 and 0), which may have been assigned
to the medium antibody component also have a non-
negligible probability of being assigned to the low
antibody component. This raises some questions
about the validity of determining a cut-oﬀ value based
on this particular mixture model.
Since data on maternal country of birth were
available from data linkage between the newborn
Table 3. Model selection strategy for mixture regression models (n=1236)
Model Model covariates
No. of
components D.F. Log-likelihood BIC
1 No covariates 3 8 x1227.1 2511.2
2 Maternal age only 3 11 x1221.1 2520.6
3 Maternal country of birth only 3 11 x1212.7 2503.7
4 Maternal country of birth
+maternal age
3 14 x1206.3 2512.3
5 Maternal country of birth
+maternal age+interaction term
3 17 x1204.4 2529.9
6 Maternal age2
+maternal age only
3 14 x1219.0 2523.7
7 Maternal age2+maternal age
+maternal country of birth
3 17 x1202.3 2525.6
8 Maternal age2+maternal age
+maternal country of birth
+interaction term
3 23 x1199.1 2561.9
D.F., Degrees of freedom; BIC, Bayesian Information Criterion.
Table 4a. Linear predictors for the optimal model
Component p m s
Low 0 x1.53+1.15 UK-born 0.74
Medium x1.88+0.14 maternal age x0.04+0.19 UK-born 0.52
High x1.88+0.13 maternal age 0.84+0.02 UK-born 0.32
Table 4b. Summary of the optimal mixture regression model with maternal age as a covariate for
the component weights (p) and maternal country of birth as a covariate for the mean of the components
(means and conﬁdence intervals have been anti-logged)
Component
No. in each
component (%)*
Mean
ODR for
women
born in UK 95% CI
Mean
ODR for
women born
abroad 95% CI
Low 48 (3.9%) 0.68 (0.41–1.15) 0.22 (0.17–0.27)
Medium 608 (49.2%) 1.17 (1.02–1.34) 0.96 (0.90–1.02)
High 580 (46.9%) 2.38 (2.16–2.62) 2.32 (2.22–2.43)
ODR, Optical density ratio ; CI, conﬁdence interval.
* The number of samples in each component was estimated using the posterior probabilities derived using equation (3).
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screening records and birth registration data, and
maternal age could be obtained from screening
datasets, ﬁnite mixture regression models could be
ﬁtted, allowing the means, component weights and
variances in the model to vary by risk factors. In
previous studies where ﬁnite mixture models have
been used, only age group has been of interest as
a predictor of antibody level [1, 3, 8], and mixture
models are therefore often stratiﬁed in order to
determine the proportion of seronegative samples
in each age group. This is important in order to
establish whether further vaccination is required due
to higher susceptibility in some cohorts. However,
maternal country of birth or ethnic group has been
reported to be a highly signiﬁcant predictor of rubella
susceptibility among pregnant women in the United
Kingdom [11, 22]. Our method allows hypotheses
about the independent, as well as the combined
eﬀects, of age and country of birth on antibody con-
centration to be tested.
In our optimal model, the means of the low and
medium components for women born abroad were
signiﬁcantly lower than those for women born in
the United Kingdom, yet the component weights were
not found to vary by country of birth. One possible
reason for this is that women born in the United
Kingdom with low antibody concentrations may
have been exposed to the virus through vaccination
several years previously and therefore their anti-
body concentrations may have waned without
‘boosting’ through contact with wild virus. This is
in contrast to women born abroad with low antibody
levels who may not have had previous virus contact.
For UK-born women, the diﬀerence in means be-
tween the low and the medium component was
not statistically signiﬁcant. A larger sample size
will allow the component means to be more pre-
cisely estimated, as well as the inclusion of a more
detailed maternal country-of-birth variable to ident-
ify speciﬁc groups at high risk of infection during
pregnancy.
We also found that the weight for the low com-
ponent decreased as maternal age increased, but
increased with maternal age for the medium compo-
nent, implying that younger pregnant women are
more likely to be seronegative, as deﬁned by the
mixture models. Vyse et al. [1] also found a similar
age pattern of rubella seronegativity among women
in England and Wales. This could be a consequence
of the antenatal screening programme, where women
who screened negative in a previous pregnancy were
vaccinated post partum.
With the possibility of adjusting for several covari-
ates, it is important that the model selection process
avoids models which overﬁt the number of compo-
nents as well as the number of covariates. The FLEXMIX
and GAMLSS.MX R-packages allow for the calculation
of BIC as a model selection statistic. In comparison
to using log-likelihood only, the BIC penalizes both
for sample size and the number of parameters, and
is therefore more conservative in terms of the opti-
mal number of components and variables included
(Table 3). The use of BIC for model selection in
ﬁnite mixture regression models depends, as all
likelihood-based procedures, on all competing models
being ﬁtted to the same dataset. Because maternal
age was missing for a large proportion of samples,
this resulted in the sample sizes for the regression
models including this covariate being reduced by
about 40%.
Several previous papers [1, 3, 8] in which mixture
models were applied to results of seroprevalence
studies have assumed normal distributions for the
mixture model components. We tested the assump-
tion that gamma-distributed mixture model compo-
nents provided a better ﬁt, however, this was found
not to be the case.
In this paper we have distinguished between the
estimates of the component weights (p1, p2, …, pK)
and the estimated proportion of observations in each
component, which is calculated based on the posterior
probabilities given in equation (3). This is the only
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Fig. 3. Component weights (p) by maternal age for the
optimal model described in Tables 4a and 4b.
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feasible approach for ﬁnite mixture regression models
ﬁtted with covariates for the component weights.
Indeed, this procedure should be used even in ﬁnite
mixture regression models without covariates for the
component weights since the posterior probabilities
allow the assessment of how well deﬁned the compo-
nents are. The posterior probabilities also allow the
analysis of the characteristics of the individuals
whose samples have been assigned to a particular
component. Using our approach, it can be shown that
60.4% of women whose samples were assigned to
the low component described in Table 4b were born
abroad. This would not have been possible if compo-
nent weights had been used to estimate the size of
the components.
The use of residual dried blood spots from new-
born screening anonymously linked to birth regis-
tration data provides a near-universal sampling frame
from a large and ethnically diverse area such as North
Thames. This allows diﬀerences in maternal rubella
antibody concentrations by maternal age and country
of birth to be investigated. We have demonstrated
that latent-class ﬁnite mixture regression models are
a powerful statistical method for analysing antibody
concentrations from serosurveys in which assay cut-
oﬀ values are not applicable. Fitting these models
allows inclusion of linear predictors for antibody
concentration and the identiﬁcation of groups of preg-
nant women who may require vaccination. Newborn
dried blood spots can therefore be used to obtain
more detailed estimates of the proportion of women
who are seronegative in diﬀerent age and country-
of-birth categories.
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